HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 259 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,412,372 | -92.4% | 12,411 | -95.9% | 0.02% | -92.9% |
Q3 2022 | $18,681,000 | -30.6% | 301,850 | -10.5% | 0.27% | -29.5% |
Q2 2022 | $26,914,000 | -25.9% | 337,434 | -2.2% | 0.38% | -10.0% |
Q1 2022 | $36,308,000 | -8.6% | 345,100 | -6.4% | 0.42% | +3.2% |
Q4 2021 | $39,720,000 | -12.9% | 368,600 | -11.4% | 0.41% | -11.7% |
Q3 2021 | $45,591,000 | +16.6% | 416,200 | -0.4% | 0.46% | +21.2% |
Q2 2021 | $39,113,000 | +4.0% | 417,700 | +2.3% | 0.38% | -4.0% |
Q1 2021 | $37,598,000 | +35.2% | 408,500 | +7.4% | 0.40% | +24.8% |
Q4 2020 | $27,812,000 | +362.6% | 380,200 | +391.2% | 0.32% | +284.3% |
Q3 2020 | $6,012,000 | -31.6% | 77,400 | -51.1% | 0.08% | -33.1% |
Q2 2020 | $8,793,000 | +78.8% | 158,200 | -4.7% | 0.12% | +30.5% |
Q1 2020 | $4,917,000 | -57.0% | 166,000 | -47.4% | 0.10% | -47.5% |
Q4 2019 | $11,428,000 | +29.8% | 315,700 | -2.4% | 0.18% | +10.4% |
Q3 2019 | $8,803,000 | +36.3% | 323,300 | +20.4% | 0.16% | +49.1% |
Q2 2019 | $6,460,000 | – | 268,500 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |